Weili Yang

2.9k total citations · 1 hit paper
110 papers, 2.1k citations indexed

About

Weili Yang is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Weili Yang has authored 110 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 28 papers in Surgery and 18 papers in Cancer Research. Recurrent topics in Weili Yang's work include Gastrointestinal Tumor Research and Treatment (14 papers), Cancer-related molecular mechanisms research (13 papers) and MicroRNA in disease regulation (11 papers). Weili Yang is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (14 papers), Cancer-related molecular mechanisms research (13 papers) and MicroRNA in disease regulation (11 papers). Weili Yang collaborates with scholars based in China, United States and Romania. Weili Yang's co-authors include Jichun Yang, Qinghua Cui, Yuhong Meng, Zhenzhen Chen, Jin‐Kui Yang, Junpei Wang, Miaomiao Zhao, Fangyuan Yang, Youchun Wang and Changfa Fan and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Diabetes.

In The Last Decade

Weili Yang

105 papers receiving 2.0k citations

Hit Papers

Cathepsin L plays a key role in SARS-CoV-2 infection in h... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weili Yang China 24 898 422 265 261 226 110 2.1k
Fang Xu China 25 870 1.0× 259 0.6× 172 0.6× 187 0.7× 275 1.2× 102 1.8k
Hong Chen China 30 1.3k 1.5× 544 1.3× 199 0.8× 267 1.0× 219 1.0× 118 2.9k
Jianying Guo China 27 969 1.1× 289 0.7× 239 0.9× 113 0.4× 271 1.2× 100 2.4k
Hui Chen China 25 1.1k 1.3× 276 0.7× 182 0.7× 170 0.7× 219 1.0× 125 2.4k
Liang Guo China 23 543 0.6× 271 0.6× 345 1.3× 198 0.8× 197 0.9× 116 1.8k
Lin Liu China 27 636 0.7× 203 0.5× 156 0.6× 332 1.3× 260 1.2× 161 2.2k
Zhihua Zheng China 24 848 0.9× 270 0.6× 219 0.8× 181 0.7× 140 0.6× 110 2.0k
Dan Tian China 23 844 0.9× 435 1.0× 92 0.3× 242 0.9× 300 1.3× 129 2.1k

Countries citing papers authored by Weili Yang

Since Specialization
Citations

This map shows the geographic impact of Weili Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Yang more than expected).

Fields of papers citing papers by Weili Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weili Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Yang. The network helps show where Weili Yang may publish in the future.

Co-authorship network of co-authors of Weili Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Weili Yang. A scholar is included among the top collaborators of Weili Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weili Yang. Weili Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Guo, Xiao Wang, Weili Yang, & Jing Lv. (2024). Life Cycle Assessment of Aviation Fuel Production from Steel-Industry Off-Gas. Processes. 12(3). 579–579. 1 indexed citations
2.
Wang, Wenxin, et al.. (2024). Inflammatory macrophage reprogramming strategy of fucoidan microneedles-mediated ROS-responsive polymers for rheumatoid arthritis. International Journal of Biological Macromolecules. 271(Pt 2). 132442–132442. 31 indexed citations
3.
Yang, Weili, Hui Liu, Xiaowei Liu, et al.. (2024). Biomimetic fucoidan nanoparticles with regulation of macrophage polarization for targeted therapy of acute lung injury. Carbohydrate Polymers. 351. 122967–122967. 4 indexed citations
4.
Chen, Yu-Sheng, et al.. (2024). Can China’s ocean governance system improve the marine ecosystem? – Taking the “bay chief system” as an example. Frontiers in Marine Science. 11. 1 indexed citations
5.
Chen, Zhou, et al.. (2023). Gastric gastrointestinal stromal tumors: therapeutic strategies and long-term prognosis. Scandinavian Journal of Gastroenterology. 59(2). 239–245.
6.
Xu, Liangliang, Weili Yang, César Serrano, et al.. (2023). Co-targeting of ACK1 and KIT triggers additive anti-proliferative and -migration effects in imatinib-resistant gastrointestinal stromal tumors. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(5). 166690–166690. 7 indexed citations
7.
Yang, Weili, Jiren Yu, Xiaodong Wang, et al.. (2022). Elevated preoperative controlling nutritional status (CONUT) scores as a predictor of postoperative recurrence in gastrointestinal stromal tumors. Journal of Surgical Oncology. 126(7). 1191–1198. 1 indexed citations
8.
Yang, Weili, Zhou Chen, Hang Yu, et al.. (2022). Reassessment of the recurrence risk of primary gastrointestinal stromal tumour after complete resection. Scandinavian Journal of Gastroenterology. 58(6). 684–692. 2 indexed citations
9.
Cao, Xi, et al.. (2022). Inhibition of STAT3 enhances UCP1 expression and mitochondrial function in brown adipocytes. European Journal of Pharmacology. 926. 175040–175040. 5 indexed citations
10.
Yang, Weili, Dong Yan, Zhixin Wang, et al.. (2022). A novel FGF23 mutation in hyperphosphatemic familial tumoral calcinosis and its deleterious effect on protein O-glycosylation. Frontiers in Endocrinology. 13. 1008800–1008800. 4 indexed citations
11.
Han, Songling, Wei Zhu, Weili Yang, et al.. (2021). A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma. Frontiers in Genetics. 12. 646818–646818. 7 indexed citations
12.
Lv, Xiaoting, Zhigang Cui, Zhihua Yin, et al.. (2018). Effects of three common polymorphisms in microRNAs on lung cancer risk: a meta-analysis. Translational Cancer Research. 7(2). 371–382. 1 indexed citations
13.
Cui, Chunmei, Weili Yang, Jiangcheng Shi, et al.. (2018). Identification and Analysis of Human Sex-Biased MicroRNAs. Genomics Proteomics & Bioinformatics. 16(3). 200–211. 98 indexed citations
14.
Huang, Chuanbo, Weili Yang, Junpei Wang, et al.. (2018). The DrugPattern tool for drug set enrichment analysis and its prediction for beneficial effects of oxLDL on type 2 diabetes. Journal of genetics and genomics. 45(7). 389–397. 10 indexed citations
15.
Yang, Weili, et al.. (2016). Diagnostic value of cerebral circulation time by DSA in patients with severe carotid artery stenosis. 4(3). 146–149. 1 indexed citations
16.
Wang, Jianfeng, et al.. (2015). Diagnostic value of non-invasive imaging modalities to evaluate lower limb arterial disease associated with diabetes. Zhonghua fangshexian yixue zazhi. 49(1). 20–24. 1 indexed citations
17.
Gao, Baoqin, et al.. (2013). Clinical and imaging characteristics of moyamoya disease in children. Zhonghua shiyong erke linchuang zazhi. 28(12). 899–901. 1 indexed citations
18.
Yang, Weili, Jiren Yu, Yijun Wu, et al.. (2009). Duodenal gastrointestinal stromal tumor: Clinical, pathologic, immunohistochemical characteristics, and surgical prognosis. Journal of Surgical Oncology. 100(7). 606–610. 41 indexed citations
19.
Chen, Dong, et al.. (2007). Gastrointestinal stromal tumors of the rectum: Clinical, pathologic, immunohistochemical characteristics and prognostic analysis. Scandinavian Journal of Gastroenterology. 42(10). 1221–1229. 21 indexed citations
20.
Yang, Weili, et al.. (2004). Recent advances in the research of mechanism of the Phenylalanine ammonia-lyase (PAL,EC 4.3.1.5) reaction. 2(4). 1–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026